CardioRisk Laboratories is a world-class service company dedicated to the early detection and monitoring of cardiovascular disease, the leading cause of morbidity and mortality in the Americas and Europe. They offer non-invasive and cost-effective products and services to identify and help reduce the incidence, morbidity, and mortality of heart attacks, strokes, and other ischemic events.
With their gold standard CardioRisk Ultrasound, they provide reliable and precise reports on Carotid Intima Media Thickness (CIMT) scans, which have proven to catch 98.6% of heart attacks and strokes before they occur. Their team of experts, including Dr. Todd Eldredge, Chief Executive Officer, and Dr. Amy Doneen, Medical Consultant, ensures that patients receive the most effective interventions to reduce cardiovascular morbidity and mortality.
Generated from the website